Evaluation
*
Strongly disagreeDisagreeSlightly disagreeNeitherSlightly agreeAgreeStrongly agree
The activity presented balanced, evidence-based content free of commercial bias.
The presenter(s) used an effective teaching strategy.
The presentation slides / digital materials / resources and handouts were high quality.
The content was relevant to / useful for my professional practice.
The activity contributed to my knowledge, skills, and capacity to enhance the delivery of patient care.
The overall quality of the educational activity was excellent.
*
Strongly disagreeDisagreeSlightly disagreeNeitherSlightly agreeAgreeStrongly agree
Identify how innovative strategies and tools are changing the way providers evaluate and manage service members and other patients following mild traumatic brain injury.
Explain how treating depressive disorders with Transcranial Magnetic Stimulation can help patients achieve full rehabilitation potential after mild traumatic brain injury.
Describe the Food and Drug Administration (FDA) approved biomarkers and medical devices that aid in evaluating and managing traumatic brain injury, including limitations and specific considerations for the military population.
Evaluate the clinical utility of Microstructure Anatomy Gradient for Neuroimaging with Ultrafast Scanning (MAGNUS) in detecting mild traumatic brain injury and its potential to inform return to duty decisions, advance research on neural biomarkers, sleep health, and cognitive performance.
*
*
*
*
*
*
*